Article Text
Editorial
Safety monitoring with ocular anti-vascular endothelial growth factor therapies
Statistics from Altmetric.com
Footnotes
-
Competing interests: AEF is an advisor to Santen, Oraya and Genentech and receives research funding from Genentech, IBI Biosciences and CoMentis. RBB has served as an advisor to OSI/Eyetech Pharmaceuticals, Pfizer, Santen and Ista Pharmaceuticals; he has no financial relationship with Genentech.